| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.JACI.2005.02.002 |
| P698 | PubMed publication ID | 15867857 |
| P50 | author | Leo Koenderman | Q37841574 |
| P2093 | author name string | Jan-Willem J Lammers | |
| Caroline A Lindemans | |||
| Bart Luijk | |||
| Deon Kanters | |||
| Mary-Ellen Bates | |||
| Paul Bertics | |||
| Roos van der Heijde | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | human eosinophil | Q101405048 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 997-1003 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge | |
| P478 | volume | 115 |
| Q26853383 | Activation states of blood eosinophils in asthma |
| Q42271746 | Acute and chronic inflammatory responses induced by smoking in individuals susceptible and non-susceptible to development of COPD: from specific disease phenotyping towards novel therapy. Protocol of a cross-sectional study |
| Q36139731 | Biomarkers of eosinophil involvement in allergic and eosinophilic diseases: review of phenotypic and serum markers including a novel assay to quantify levels of soluble Siglec-8 |
| Q39627809 | Chemoattractant-Induced Signaling via the Ras–ERK and PI3K–Akt Networks, along with Leukotriene C4 Release, Is Dependent on the Tyrosine Kinase Lyn in IL-5– and IL-3–Primed Human Blood Eosinophils |
| Q38134713 | Clinical utility of asthma biomarkers: from bench to bedside |
| Q48010388 | Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness |
| Q33785627 | Eosinophil Activation Status in Separate Compartments and Association with Asthma |
| Q26771819 | Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease |
| Q36059786 | Eosinophils in the pathogenesis of allergic airways disease. |
| Q34499280 | Fc receptor inside-out signaling and possible impact on antibody therapy. |
| Q37206758 | Human airway eosinophils exhibit preferential reduction in STAT signaling capacity and increased CISH expression |
| Q33982401 | Human airway eosinophils respond to chemoattractants with greater eosinophil-derived neurotoxin release, adherence to fibronectin, and activation of the Ras-ERK pathway when compared with blood eosinophils |
| Q37165737 | Human eosinophil activin A synthesis and mRNA stabilization are induced by the combination of IL-3 plus TNF. |
| Q36161520 | IL-3 and TNFα increase Thymic Stromal Lymphopoietin Receptor (TSLPR) expression on eosinophils and enhance TSLP-stimulated degranulation |
| Q48014771 | IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. |
| Q35813671 | Platelet activation, P-selectin, and eosinophil β1-integrin activation in asthma |
| Q33883158 | Priming of eosinophils by GM-CSF is mediated by protein kinase CbetaII-phosphorylated L-plastin |
| Q39377433 | Regulation of Eosinophil Recruitment and Activation by Galectins in Allergic Asthma |
| Q49751199 | Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease |
| Q57158533 | Shall We Focus on the Eosinophil to Guide Treatment with Systemic Corticosteroids during Acute Exacerbations of COPD?: PRO |
| Q42496152 | Systemic eosinophil response induced by respiratory syncytial virus |
| Q38764451 | The current and future role of biomarkers in type 2 cytokine-mediated asthma management |
Search more.